We’re pleased to announce that our co-founders, Drs. Houfar Sekhavat and Nir Shoham-Hazon, will be attending Eyecelerator and the American Academy of Ophthalmology (AAO) 2024 from October 17 to 21 in Chicago! These events are must-attends for anyone passionate about the future of emerging technologies aimed at accelerating ophthalmic innovation. We look forward to engaging with innovators in the field, collaborating with colleagues, fostering impactful connections, and sharing the work we’re doing at Hexiris. #OphthalmicInnovation #Ophthalmology #GlaucomaTreatment #MedicalDevices #Eyecelerator #AAO2024
Hexiris
Medical Equipment Manufacturing
Dieppe, New Brunswick 397 followers
Developing MIGS solutions to be delivered out of the Operating Room. Medical solutions for ocular diseases.
About us
Hexiris is an Ophthalmologist-based Pharma company. Our goals are the innovation of the Next Generation MIGS and novel Ophthalmic drugs. PM us for more info.
- Industry
- Medical Equipment Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Dieppe, New Brunswick
- Type
- Privately Held
- Founded
- 2019
- Specialties
- MIGS, Glaucoma, Medical Devices, and Ophthalmology
Locations
-
Primary
Get directions
Dieppe, New Brunswick, CA
Employees at Hexiris
Updates
-
Discover the future of glaucoma treatment with Hexiris at The MedTech Conference in Toronto, October 15-17, 2024! We will be on-site to connect with investors and medtech innovators, exploring exciting opportunities for collaboration and growth. Learn more about our cutting-edge MIGS 2.0 device, designed to revolutionize minimally invasive glaucoma surgery. We look forward to meeting you there! #GlaucomaTreatment #MedicalDevices #Ophthalmology #MedTechCon #MTC24
-
-
Hexiris reposted this
Leading Ophthalmologist in MedTech Innovation at Hexiris Inc with Next Generation MIGS expertise.
If you’re not registered yet. It’s time to register!!! 🙏 It’s a huge honour to collaborate with Paul Harasymowycz, MD and Amanda Antao to talk about this amazing technology of Canaloplaty - ab interno (and externo) that Nova Eye Medical brings us. Join our webinar. Nova Eye Medical @itrackadvance
-
-
Hexiris reposted this
Leading Ophthalmologist in MedTech Innovation at Hexiris Inc with Next Generation MIGS expertise.
Honoured to have this paper published in the Canadian Eye Care Today. 👁️ What a pleasure to have collaborated with Dr. Dubinsky-Pertzov.🙏 Special thanks to Medhaj Garg for his contribution.
-
-
We are excited to welcome Ken Johannaber to the Hexiris team as our Chief Project Officer. With over 20 years of experience in medical device development and commercialization, Ken has an impressive background, including 30 patents and roles such as Managing Director of a surgeon-focused design consultancy and VP of Engineering and Quality. Ken's expertise and experience make him a great addition to our team. #Hexiris #MedicalDevices #HealthcareIndustry #MedTech #Innovation https://hexiris.ca
-
Hexiris reposted this
Leading Ophthalmologist in MedTech Innovation at Hexiris Inc with Next Generation MIGS expertise.
And that’s a wrap!!! Hexiris @ BIO San Diego Thanks to all our partners and supporters. Was an honour and pleasure to meet the movers and shakers of innovation in New Brunswick, Canada. Bruce Fitch Houfar Sekhavat Margaret Melanson Damon Goodwin Jennifer Sheils @investincanada Horizon Health Network
-
-
Proud of our team at BIO San Diego.
Leading Ophthalmologist in MedTech Innovation at Hexiris Inc with Next Generation MIGS expertise.
Hexiris is at BIO San Diego - day 3. Amazingly productive day with loads of leads. Promising potential partnerships. Thanks a lot Damon Goodwin and ResearchNB for your support. Houfar Sekhavat Jean-Philippe Gravel, MBA
-
-
Hexiris reposted this
Discover the future of glaucoma treatment with Hexiris at the BIO International Convention in San Diego, CA, June 3-6! Meet our co-founders, Dr. Nir Shoham-Hazon MD and Dr Houfar Sekhavat, and learn more about our cutting-edge MIGS 2.0 device. Join us as we redefine the treatment paradigm of glaucoma therapy and improve patient access to care. #BIO2024 #GlaucomaTreatment #MedicalDevices #OphthalmologyInnovation #BIOInternationalConvention
-
-
Discover the future of glaucoma treatment with Hexiris at the BIO International Convention in San Diego, CA, June 3-6! Meet our co-founders, Dr. Nir Shoham-Hazon MD and Dr Houfar Sekhavat, and learn more about our cutting-edge MIGS 2.0 device. Join us as we redefine the treatment paradigm of glaucoma therapy and improve patient access to care. #BIO2024 #GlaucomaTreatment #MedicalDevices #OphthalmologyInnovation #BIOInternationalConvention
-
-
Proud to see our Co-Founder and Co-CEO taking the podium at the American Society of Cataract and Refractive Surgery (ASCRS) speaking about innovative technology in the exciting MIGS space. Hexiris
🎥 🇨🇦 Here is one of our favorite surgeon collaborators, Nir Shoham-Hazon MD, Canada, sharing canaloplasty results from the International Glaucoma Surgery Registry at the recent American Society of Cataract and Refractive Surgery (ASCRS) in Boston - including the clinical outcomes of patients with primary angle closure glaucoma (PACG) who underwent treatment with the iTrack™ Advance. See here: https://lnkd.in/g4pHiJiQ Thank you for the ❤️ Ophthalmology Times ------------------------ The iTrack™ Advance has been cleared for the indication of fluid infusion and aspiration during surgery, and for catheterization and viscodilation of Schlemm’s canal for the reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma. * Note: The iTrack™ Advance has not been cleared for the reduction of intraocular pressure (IOP) in adult patients with primary angle closure glaucoma. The iTrack™ Advance has a CE Mark (Conformité Européenne) and US Food and Drug Administration (FDA) 510(k) #K221872 for the treatment of open-angle glaucoma. #glaucoma #canaloplasty #iTrackAdvance #iTrack
ASCRS 2024: Safety and efficacy of Canaloplasty with the iTrack Advance
ophthalmologytimes.com